PHARMA IN FOCUS By Tiffany Walker 20 January 2023 ST Notches Another Win Specialised Therapeutics (ST) has scored approval for Qinlock in New Zealand, marking the second of five regions that the company has rights to commercialise the advanced gastrointestinal stromal tumour (GIST) treatment. The Singapore headquartered company was established to commercialise new therapies and